Using reported pathogenic variants to identify therapeutic opportunities for genetic diseases.
Andrew K ResslerDavid B GoldsteinPublished in: Molecular genetics & genomic medicine (2022)
We suggest a set of 16 genes suitable for drug developmental efforts utilizing direct inhibition.